| Literature DB >> 29040556 |
Rodrigo M Carrillo-Larco1, Andrea Ruiz-Alejos1, Antonio Bernabé-Ortiz1,2, Robert H Gilman1,3, Liam Smeeth2, J Jaime Miranda1,4.
Abstract
Entities:
Mesh:
Year: 2017 PMID: 29040556 PMCID: PMC5837622 DOI: 10.1093/ije/dyx116
Source DB: PubMed Journal: Int J Epidemiol ISSN: 0300-5771 Impact factor: 7.196
Figure 1Number of participants in each round of the PERU MIGRANT Study. The percentages for follow-up rates do not include deaths in each group.
Characteristics of PERU MIGRANT Study participants at first follow-up round: deaths, lost-to-follow up and re-contacted
| Re-contacted participants | Lost-to- follow-up participants | ||
|---|---|---|---|
| Dead | Alive | Overall | |
| Migration status | |||
| Rural | 10 (30.3) | 191 (21.3) | 0 (0.0) |
| Migrant | 14 (42.4) | 526 (58.8) | 49 (80.1) |
| Urban | 9 (27.3) | 178 (19.9) | 12 (19.9) |
| Age (years) | |||
| 30–39 | 3 (9.1) | 259 (28.9) | 20 (32.8) |
| 40–49 | 1 (3.0) | 263 (29.4) | 18 (29.6) |
| 50–59 | 7 (21.2) | 252 (28.2) | 13 (21.4) |
| 60+ | 22 (66.7) | 121 (13.5) | 10 (16.4) |
| Sex | |||
| Male | 22 (66.7) | 413 (46.1) | 32 (52.5) |
| Female | 11 (33.3) | 482 (53.9) | 29 (47.5) |
| Education | |||
| Primary or less | 24 (72.7) | 430 (48.4) | 26 (42.6) |
| Some secondary or more | 9 (27.3) | 463 (51.6) | 35 (57.4) |
| Asset index | |||
| Lowest | 19 (57.8) | 313 (35.0) | 15 (24.6) |
| Middle | 8 (24.2) | 294 (32.9) | 25 (40.9) |
| Highest | 6 (18.1) | 288 (32.2) | 21 (34.4) |
The entries in parentheses refer to the corresponding percentages (%).
Characteristics of PERU MIGRANT Study participants at first follow-up round, i.e. deaths, lost-to-follow-up and re-contacted according to study group
| Re-contacted participants | Lost-to-follow-up participants | |||
|---|---|---|---|---|
| Rural | Migrant | Urban | Overall | |
| Mortality | 10 (5.0) | 14 (2.6) | 9 (4.8) | – |
| Age (years) | ||||
| 30–39 | 20 (9.9) | 64 (11.9) | 23 (12.4) | 60 (98.4) |
| 40–49 | 59 (29.4) | 157 (29.4) | 48 (25.9) | 1 (1.6) |
| 50–59 | 43 (21.4) | 158 (29.3) | 57 (30.8) | – |
| 60+ | 55 (27.4) | 135 (25.0) | 47 (25.4) | – |
| Sex | ||||
| Male | 95 (47.3) | 252 (46.7) | 88 (47.1) | 32 (52.5) |
| Female | 106 (52.7) | 288 (53.3) | 99 (52.9) | 29 (47.5) |
| Education | ||||
| None/some | 132 (65.6) | 168 (31.2) | 13 (6.9) | 15 (24.6) |
| Primary complete | 30 (14.9) | 92 (17.1) | 19 (10.2) | 11 (18.0) |
| Some secondary or more | 39 (19.4) | 279 (51.7) | 154 (82.8) | 35 (57.4) |
| Asset index | ||||
| Lowest | 196 (97.5) | 108 (20.0) | 28 (14.9) | 15 (24.6) |
| Middle | 5 (2.5) | 233 (43.2) | 64 (34.2) | 25 (40.9) |
| Highest | 0 (0.0) | 199 (36.9) | 95 (50.8) | 21 (34.4) |
The entries in parentheses refer to the corresponding percentages (%).
Characteristics of PERU MIGRANT study participants at second follow-up
| Re-contacted participants | |||
|---|---|---|---|
| Rural | Migrant | Urban | |
| Mortality | 13 (8.4) | 30 (5.8) | 14 (8.1) |
| Age (years) | |||
| 30–39 | – | – | – |
| 40–49 | 41 (29.5) | 147 (30.3) | 43 (26.7) |
| 50–59 | 37 (30.3) | 153 (31.5) | 53 (32.9) |
| 60+ | 61 (26.7) | 186 (38.7) | 65 (40.4) |
| Sex | |||
| Male | 63 (40.9) | 241 (46.4) | 77 (44.5) |
| Female | 91 (59.1) | 279 (53.7) | 96 (55.5) |
| Education | |||
| None/some | 101 (65.6) | 164 (31.6) | 12 (7.0) |
| Primary complete | 22 (14.3) | 90 (17.3) | 18 (10.4) |
| Some secondary or more | 31 (20.1) | 265 (51.1) | 142 (82.6) |
| Asset index | |||
| Lowest | 149 (96.8) | 103 (19.8) | 29 (16.8) |
| Middle | 5 (3.5) | 222 (42.7) | 60 (34.7) |
| Highest | 0 (0.0) | 195 (34.7) | 95 (48.6) |
The entries in parentheses refer to the corresponding percentages (%).
Information collected at each study round, the PERU MIGRANT Study
| Phase | Information collected | |
|---|---|---|
| Baseline 2007–08 | Laboratory | Fasting glucose, fasting insulin, glycosylated haemoglobin, lipid profile (total cholesterol, HDL-c, triglycerides), high ultrasensitive C-reactive protein, self-reported socioeconomic position |
| Clinical examination | Anthropometric measurements: weight, waist and hip circumferences, skinfolds (subcapsular, biceps, triceps and supra-iliac), blood pressures | |
| Questionnaire | Self-reported NCDs (myocardial infarction, stroke, type 2 diabetes mellitus, dyslipidaemia), alcohol consumption, smoking status, mental health (12-item general health questionnaire), medication (specially antihypertensive and hypoglycaemic agents), socioeconomic factors, physical activity level (IPAQ), a social capital instrument validated in Peru, acculturation scale, Rose angina questionnaire | |
| First follow-up 2012–13 | Clinical examination | Anthropometric measurements: weight, height, waist and hip circumferences, blood pressures |
| Questionnaire | Self-reported NCDs, alcohol consumption, smoking status, mental health (12-item general health questionnaire), medication (specially antihypertensive and hypoglycaemic agents), verbal autopsy and death certificates if available | |
| Second follow-up 2015–16 | Laboratory | Fasting glucose |
| Clinical examination | Weight, body composition (bioimpedance) and blood pressure measurements, assessment using electrocardiogram (ECG) | |
| Questionnaire | Questions related to the occurrence of cardiovascular diseases and/or risk factors such as previous diagnosis of myocardial infarction, hypertension, stroke, diabetes, physical activity level (IPAQ); plus self-rated status of health, medication and the patient health questionnaire (PHQ-9; mental health status) | |
Personal histories of cardiovascular diseases and other non-communicable diseases were self-reported.